| 000 | 01131 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515014716.0 | ||
| 264 | 0 | _c20060426 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a1743-4270 | ||
| 024 | 7 |
_a10.1038/ncpuro0321 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEastham, James A | |
| 245 | 0 | 0 |
_aProstate-specific antigen doubling time as a prognostic marker in prostate cancer. _h[electronic resource] |
| 260 |
_bNature clinical practice. Urology _cOct 2005 |
||
| 300 |
_a482-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Failure |
| 773 | 0 |
_tNature clinical practice. Urology _gvol. 2 _gno. 10 _gp. 482-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/ncpuro0321 _zAvailable from publisher's website |
| 999 |
_c16086855 _d16086855 |
||